Transpek Industry Limited · BSE:TRANSPEK
Transpek Industry — Investor Presentation (June 2022)
38 slides from Transpek Industry's investor presentation, Jun 10, 2022
Slide 1: BSE cover letter for investor presentation
+91 265 6700 300 PHONE ......... Transpek_ Industry limited vTranspel\ Reg. Office: 4th Floor, Lilleria 1038 Gotri - Sevasi Road rearlve Chemis1ry Vadodara - 390021. Gujarat, (India) Date: 10th June, 2022 To, BSE Limited P.J. Towers, Dalal Street, Mumbai -400 001 Ref: Scrip Code: 506687 Subject: Inv
Slide 2: Investor Presentation June 2022
Transpek Industry Limited Investor Presentation June 2022
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Transpek Industry Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se
Slide 4: Q4 FY22 - Financial Highlights
Q4 FY22 - Financial Highlights
Slide 5: Business Highlights (1/2)
Business Highlights (1/2) • The end-application market has picked up its pace after the COVID situation, which has led to a significant improvement in the overall performance of the company in FY22 as compared to the previous year. • There is significant uncertainty in terms of raw material prices,
Slide 6: Business Highlights (2/2)
Business Highlights (2/2) • Many raw materials are imported and have very limited suppliers. Considering the overall supply chain issues, the Company works with the customers in close cooperation to ensure timely sourcing of raw materials so as to minimize the impact on production. • As highlighted
Slide 7: Performance Highlights
Performance Highlights Revenue* (Rs. In Cr) FY22 Sales Distribution based on Application 6.8% Polymer 12.6% +76% Pharma 627.5 12.7% Specialty 60.2% Others 356.7 FY22 - Revenue Breakup FY21 FY22 31.3% International EBITDA* (Rs. In Cr) PAT (Rs. In Cr) Domestic 76.2% Margin 18.1% 19.8% 6.5% 10.4% +93.0
Slide 8: Performance Highlights
Performance Highlights Q4 FY22 Sales Distribution based on Revenue* (Rs. In Cr) Application +45% 6.2% 190.6 Polymer 16.3% 158.4 Pharma 146.5 132.0 52.0% Specialty 15.3% 101.2 Others Q4 FY22 - Revenue Breakup Q4FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4FY22 26.1% International EBITDA* (Rs. In Cr) PAT (Rs. In Cr
Slide 9: Q4FY22 - Consolidated Profit & Loss Account
Q4FY22 - Consolidated Profit & Loss Account Particulars (Rs. Crores) Q4FY22 Q4FY21 Y-o-Y FY22 FY21 Y-o-Y Revenue from Operations 142.7 96.5 599.1 339.4 Other Income 3.8 4.7 28.4 17.3 Total Revenue from operations 146.5 101.2 44.8% 627.5 356.7 75.9% Cost of materials consumed 78.8 44.3 332.9 159.3 Pu
Slide 10: FAQ's
FAQ’s • The management periodically reviews the situation and would announce any significant change in the status. Project & Capex • The Capex for next two years will be based on the timing of the introduction of new products and any significant investment will be announced appropriately. • The comp
Slide 11: Transpek at Glance
Transpek at Glance
Slide 12: About us
About us Environment Protection Founded by Shri. Govindji Shroff in 1965 Over 5 decades Creative Over three Part of Excel experience in Chemistry decades of presence in the group of Sulphur and international companies Chlorine market Chemistry Customer Exploring every Headquartered Focus possible in
Slide 13: Our journey over five decades
Our journey over five decades 2017 Long term supply agreement with global chemical giant 2018 Started supplying under long 2004 term supply agreement and Set up of First Multi Purpose became big global player in acid Acid Chloride Plant chlorides 2012 1987 Significant strategic shift from Started ma
Slide 14: Our products are supplied to varied industries
Our products are supplied to varied industries Leading global supplier for ‘Chlorinated Products’ to various industry sectors FY22 Sales Distribution based on Application ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. Polymers Pharma Specialty Chemicals 6.8% 12.6% Polymer Pharma S
Slide 15: Our products have multiple applications
Our products have multiple applications Diversified Products Across India’s Fastest Growing Industries • 2, 4, 6 Trimethyl Benzoyl • 2-Methoxyethyl chloride • 2-Chloroethylamine • 2-Chloroethylamine Chloride • Cocoyl Chloride Hydrochloride Solution • 2-Propoxyethyl chloride Hydrochloride Solution •
Slide 16: Our capabilities developed over years
Our capabilities developed over years Research & Development Sustainability Ratings ◊ In house development of products ◊ ECOVADIS Sustainability platform – the company is ◊ DSIR approved R&D Facility rated very high with ‘Silver Badge’ ◊ R&D Lab approved by MS University of Baroda for ◊ One of those
Slide 17: Our clients trust in our capabilities & chemistries
Our clients trust in our capabilities & chemistries Company has built an excellent reputation globally – Testament to our Reliability and Trustworthiness Long-term supply agreement commenced from 1st January 2018 Contract 10 years Period Exclusive contract with a High performance product with dedica
Slide 18: Our plants are multipurpose and multiproduct
Our plants are multipurpose and multiproduct Ekalbara Located ~25 km away from the headquarter location at Vadodara, Gujarat. Dedicated multipurpose and multiproduct plants spread over 100 acres with total production capacity of 66,000 • Strategically located in largest chemical MTPA. manufacturing
Slide 19: Our R & D facility is recognized by Government of India
Our R & D facility is recognized by Government of India Research & Development Developed a comprehensive in-house R&D facility recognized by the Department of Science & Technology, Government of India, which is equipped with latest technology and equipment Every new and existing product undergoes a
Slide 20: Our top management is committed to process safety
Our top management is committed to process safety PHA Chemical Release • Process Hazard Analysis 01 • Dispersion Modeling Studies conducted for all products and • Storage Quantity Reduction processes 02 • Mechanical Integrity of Equipment Top Management 06 PSSR • Total commitment and • Pre-Startup s
Slide 21: Our transportation is safe, systematic and sustainable
Our transportation is safe, systematic and sustainable Logistics Safe, systematic and sustainable transportation is a key challenge to ever changing global chemical industry Pioneers in developing in-house ISO Tank station which is well equipped with state-of-the-art technology We manage over 600 IS
Slide 22: Our products are delivered across the globe
Our products are delivered across the globe FY22 - Revenue Breakup One of the Pioneering Global Exporters from India since 1986 Long term relations with Leading Global Chemical Giants 31% Sweden 76% Spain Germany Russia France Italy Switzerland Domestic International U.S.A. Japan China South Korea T
Slide 23: Our board has vast industry experience
Our board has vast industry experience Mr. Ashwin C. Shroff | Chairman Mr. Ninad D. Gupte | Independent Director He is a B.Sc degree from Bombay University, PGDBM (XLRI-Jamshedpur), and Diploma in He is a science graduate, Mr. Shroff have emerged stronger, helping the growth of Tax Management (Bajaj
Slide 24: Our company has adopted a sustainable method of doing business
Our company has adopted a sustainable method of doing business Community Empowerment Biodiversity Serving the society in various areas Maintaining and enhancing green belt (flora and like health & hygiene, education, skill fauna) within the factory premises through development, vocational training e
Slide 25: ESG at the heart of all we do
ESG at the heart of all we do
Slide 26: Corporate social responsibility
Corporate social responsibility Women Empowerment Workshops Vocational Training Understanding the needs of communities, addressing them Our vision is to actively contribute towards through need-based projects and making them work together creating innovative and sustainable solutions in to help crea
Slide 27: Awards and Recognitions – A glimpse
Awards and Recognitions – A glimpse Government of Gujarat: FGI Award for Excellence in the field of Indian Chemical Council: Excellence in CSR Award Environment Pollution Abatement & Best in Social Responsibility Award Preservation Shri Atul Shroff, Director & Union Leader Shri Shri Bimal V. Mehta,
Slide 28: Environment, health and safety
Environment, health and safety Rainwater harvesting and recharging Green cover in Transpek premise Safety is our responsibility We have Full-fledged Effluent management system with a licensed discharge facility to the central Effluent channel Our company has 100 acres of land with a green belt of mo
Slide 29: Socially responsible at the time of COVID – 19
Socially responsible at the time of COVID – 19 Activities done during COVID-19: Arranged for immunity boosting medicines including multi vitamins, zinc and iron sucrose injections, as per the requirements of Primary Health Centre – Mujpur, along with gloves and sanitizer bottles for their health sta
Slide 30: Historical Financial Highlights
Historical Financial Highlights
Slide 31: FY22 – Consolidated Profit & Loss Account
FY22 – Consolidated Profit & Loss Account Particulars (Rs. Crores) FY22 FY21 Y-o-Y Revenue from Operations 599.1 339.4 Other Income 28.4 17.3 Total Revenue from operations 627.5 356.7 75.9% Cost of materials consumed 332.9 159.3 Purchases of stock-in-trade 0.0 0.0 Changes in inventories of finished
Slide 32: Mar'22 - Consolidated Balance Sheet
Mar’22 - Consolidated Balance Sheet Liabilities (Rs. Crores) Mar-22 Mar-21 Assets (Rs. Crores) Mar-22 Mar-21 Equity Non Current assets Equity Share capital 5.6 5.6 Property, Plant and Equipment 287.1 271.5 Other Equity 478.7 374.2 Capital work-in-progress 16.1 13.9 Right to use of lease assets 7.4 1
Slide 33: Mar'22 - Consolidated Cash Flow Statement
Mar’22 - Consolidated Cash Flow Statement Particulars (Rs. Crores) Mar-22 Mar-21 Net Profit Before Tax 84.2 25.5 Adjustments for: Non Cash Items / Other Investment or Financial Items 35.2 33.6 Operating profit before working capital changes 119.5 59.1 Changes in working capital -49.7 -20.9 Cash gene
Slide 34: Consolidated Financial Highlights
Consolidated Financial Highlights Revenue* (Rs. In Cr) EBITDA* (Rs. In Cr) PAT (Rs. In Cr) 15.3% 21.9% 23.2% 18.1% 19.8% 7.1% 10.7% 12.5% 6.5% 10.4% Margin 612.4 627.5 583.0 150 134.4 135.3 80 73.0 124.5 65.7 65.4 60 370.9 356.7 100 56.9 64.4 40 26.4 23.3 50 20 0 0 FY18 FY19 FY20 FY21 FY22 FY18 FY19
Slide 35: Consistent Dividend Performance
Consistent Dividend Performance Dividend Dividend Per Share 240 27 225% 220 200% 200 20.0 22.5 180 160 18 140 125% 120 100 90% 90% 12.5 80 75% 75% 9 9.0 9.0 60 50% 7.5 7.5 40 25% 5.0 20 2.5 0 0 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 34
Slide 36: Way Forward
Way Forward
Slide 37: Strategic Growth - Two-Fold Approach
Strategic Growth - Two-Fold Approach • First approach is to add products that are similar to current products in chemistry profile but have varied First Approach applications. This would help in growing in the areas that are well known by the Company and also the Company has carried a solid reputati
Slide 38: Thank You
Contact Information Company : Investor Relations Advisor : Transpek Industry Limited Strategic Growth Advisors Pvt. Ltd. CIN: L23205GJ1965PLC001343 CIN: U74140MH2010PTC204285 Mr. Alak D. Vyas Mr. Shrikant Sangani / Ms. Pankti Majithia E: shrikant.sangani@sgapl.net / pankti.majithia@sgapl.net E: secr
Transpek Industry — Investor Presentation (June 2022) on 6ix